Bromfenac 0.09% for the Treatment of Macular Edema Secondary to Noninfectious Uveitis

PURPOSE: The topical nonsteroidal anti-inflammatory drug bromfenac 0.09% has a potential benefit in uveitic macular edema (UME) with a safe side effect profile. The aim of the study is to assess the efficacy of bromfenac sodium solution in the treatment of UME. METHODS: The charts of 10 patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Saade, Joanna S., Istambouli, Rachid, AbdulAal, Marwan, Antonios, Rafic, Hamam, Rola N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547661/
https://www.ncbi.nlm.nih.gov/pubmed/34759667
http://dx.doi.org/10.4103/meajo.meajo_134_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547661/
https://www.ncbi.nlm.nih.gov/pubmed/34759667
http://dx.doi.org/10.4103/meajo.meajo_134_21

Ejemplares similares